☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
CTI BioPharma. Vonjo
CTI BioPharma’s Vonjo (pacritinib) Receives the US FDA’s Accelerated Approval for the Treatment of Myelofibrosis and Thrombocytope...
February 28, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.